Enigmatig Limited Stock Price, News & Analysis

EGG NYSE

Welcome to our dedicated page for Enigmatig news (Ticker: EGG), a resource for investors and traders seeking the latest updates and insights on Enigmatig stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Enigmatig's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Enigmatig's position in the market.

06/20/2025 04:30 PM

News

Enigmatig Limited Announces Closing of US$15 Million Initial Public Offering, Including Exercise of Over-allotment Option

Rhea-AI Summary

Enigmatig Limited (NYSE American: EGG), a consultancy firm specializing in cross-border licensing solutions, has successfully completed its Initial Public Offering (IPO). The company sold a total of 3,005,200 Class A ordinary shares at US$5.00 per share, which includes an additional 160,000 shares from the exercise of the over-allotment option. The IPO generated total gross proceeds of US$15,026,000 before deducting underwriting discounts and commissions. Prime Number Capital, LLC served as the sole bookrunner for the offering, which was conducted on a firm commitment basis. The offering was made through a prospectus following the registration statement's effectiveness with the SEC.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-17.34%

Enigmatig Limited Announces Pricing of Initial Public Offering

Rhea-AI Summary

Enigmatig Limited, a consultancy firm specializing in cross-border licensing solutions, has announced the pricing of its IPO. The company will offer 2,845,200 Class A ordinary shares at US$5.00 per share, with trading expected to commence on June 18, 2025, on the NYSE American Market under the symbol 'EGG'. The underwriter, Prime Number Capital LLC, has been granted a 45-day option to purchase up to 426,780 additional shares to cover potential over-allotments. The IPO is expected to close around June 20, 2025, subject to standard closing conditions. The offering is being conducted on a firm commitment basis, with Prime Number Capital acting as the sole bookrunner.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %